EGFR and non-small cell lung carcinoma: Currently, among the various blood EGFR mutation detection techniques, SuperARMS technology is a highly sensitive and specific method suitable for non‐invasive detection of advanced NSCLC patients with plasma EGFR mutation detection, the detection sensitivity of EGFR mutation detection in plasma samples can reach 0.2%, which is can effectively predict the efficacy of EGFR‐TKIs and guide clinical medication.27, 28, 29